Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
While the link is still being investigated, intriguing findings suggest that glutathione levels could impact the well-being of individuals on the autism spectrum
The Enforcement Escalation The 12 months before Peptide Sciences shut down saw the most aggressive regulatory enforcement campaign the research peptide market has ever experienced: December 2024: FDA issues warning letters to Prime Peptides, Xcel Peptides, SwissChems, and Summit Research for selling semaglutide, tirzepatide, and retatrutide as unapproved drugs
In the pivotal STRATUM trial, nearly 80% of individuals achieved the primary efficacy endpoint of Investigators Global Assessment (IGA) Success, with just over 50% reaching complete clearance at week 8
The fact that a derivative PT-141 (bremelanotide) eventually received FDA approval for a different indication underscores that therapeutic potential must be paired with rigorous testing, quality control, and medical supervision
